STEINMAN LAWRENCE purchased 200.9% of their position (133.33K shares) of PASITHEA THERAPEUTICS CORP. on the open market
Open‑market purchase worth $100.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/1/2025ACC: 0001213900-25-116309
Director
Since Sep 2021
+133.33K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
133.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+133.33K
Price / share
$0.75
Trade value
$100K
% of position
200.9%
11/28/2025
66.36K→199.69K
Total
Net shares
+133.33K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/28/2025 | P · Purchase | +133.33K | $0.75 | $100K | 200.9% | 66.36K | 199.69K |
| Total | +133.33K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported